AJANTPHARM evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

Financial data quality flags require resolution.
A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage: FULL_STATEMENTS
Financial source retrieved: 2026-08-26T23:16:15.770361+00:00

Metrics

latest_annual_period: 2026-03-31
revenue: 54528600000.0
net_income: 10560000000.0
operating_cash_flow: 5163900000.0
free_cash_flow: 1512300000.0
total_assets: 61548400000.0
total_liabilities: 16277500000.0
total_equity: 45270900000.0
cash: 6646200000.0
total_debt: 2601700000.0
revenue_growth: 0.18863174140219852
earnings_growth: 0.1473397146861657
net_margin: 0.19365984089083527
roe: 0.23326242685698761
debt_to_equity: 0.05746958863199097
cash_conversion: 0.4890056818181818
free_cash_flow_margin: 0.027734069827576723
trailing_pe: 38.6486
forward_pe: 27.5482
peg_ratio: Not supplied
price_to_book: 9.6293
dividend_yield: 0.008

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Trend Continuation Pullback

Research only. Direction: LONG.

Tests continuation after a controlled retracement within an established trend

No active, unexpired validation authority for this exact strategy and horizon.
A source-backed entry, invalidation, exit and cost plan is not supplied.

Eligible expression: None selected
Expression comparison: No eligible instrument selected.

Invalidation: Price breach below slow EMA
Entry rule: Not supplied
Entry range (INR): Not supplied
Exit / review rule: Not supplied
Planned exit: Not supplied
Plan valid until: Not supplied
Promotion reference: Not supplied

Instrument scenarios in INR; quantities are illustrative, not personal sizing
Instrument	Evidence status	Contract	Quantity	Capital / margin	Target P&L after costs	Stop-level scenario P&L	Stress loss	Conditions and limitations
NO_POSITION	Available	Not supplied	Not supplied	Not supplied	0.00	0.00	Not supplied	No new position; incremental trading P&L is zero.
CASH	Unavailable	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Observed contract, quote and cost evidence not supplied.
FUTURES	Unavailable	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Observed contract, quote and cost evidence not supplied.
OPTIONS	Unavailable	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Observed contract, quote and cost evidence not supplied.

No reader capital or loss budget supplied

Decision provenance and limitations

Decision ID: decision-affc3625676ba1a7faaf4a7b69f42dff2bef144de94094c41dda6e330415311e
Policy: stock-decisions-v1
Evidence bundle hash: cb4d85be21586347198ca1e3501842b2e89f621bcd9dadf6bb7dd52b571c6052

market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
financial-statements: fafcdecf5cd2e985e077a77577b2a6bf449a2a3c3b551ef5165b6b3a325b242e
daily-price: e876a28994cfbe51955445d8f24bd5b22053dd4820b87ef430e271ca9788cfcb

Conditional research decisions are not orders or personalized position sizes.
Scenario payoffs are assumptions, not probabilities or expected returns.
A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 3581.00. The trailing 5-session price return was 1.17%. The trailing 20-session price return was 2.85%. The trailing 60-session price return was 10.22%. The trailing 250-session price return was 46.80%.

Risks

The closing price was -3.69% below its highest close in the available trailing year. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.

Follow Up

Average cached traded value over twenty sessions was INR 316,167,379. The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.18863174140219852. The cached financial metric net margin is 0.19365984089083527. The cached financial metric roe is 0.23326242685698761. The cached financial metric debt to equity is 0.05746958863199097.

Cached observations and evidence limits

Price source verification: REPAIRED.
The cached closing price on 2026-10-01 was INR 3581.00.
The trailing 5-session price return was 1.17%.
The trailing 20-session price return was 2.85%.
The trailing 60-session price return was 10.22%.
The trailing 250-session price return was 46.80%.
Average cached traded value over twenty sessions was INR 316,167,379.
The closing price was -3.69% below its highest close in the available trailing year.
Fundamental coverage is FULL_STATEMENTS; retrieved 2026-08-26T23:16:15.770361+00:00 from EODHD.
The cached financial metric latest annual period is 2026-03-31.
The cached financial metric revenue growth is 0.18863174140219852.
The cached financial metric net margin is 0.19365984089083527.
The cached financial metric roe is 0.23326242685698761.
The cached financial metric debt to equity is 0.05746958863199097.
The cached financial metric cash conversion is 0.4890056818181818.
The cached financial metric free cash flow margin is 0.027734069827576723.
Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.
Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.